Russian Direct Investment Fund's Dmitriev on Russia's COVID-19 Vaccine

The transcript discusses the development and distribution of a Russian vaccine based on human adenovirus technology. It highlights the ongoing trials, global interest, and agreements for over a billion doses. The discussion also covers the political challenges faced in Europe and the safety and efficacy of the vaccine compared to others like AstraZeneca. The speaker emphasizes the importance of separating politics from healthcare and the need for long-term studies on other vaccine technologies.

What is the significance of the Russian Direct Investment Fund in the context of the vaccine?

How does the speaker view the relationship between politics and vaccine distribution?

What are the long-term studies mentioned regarding the vaccine?